首页 > 最新文献

CMAJ open最新文献

英文 中文
Partnering For Pain: a Priority Setting Partnership to identify patient-oriented research priorities for pediatric chronic pain in Canada. 疼痛伙伴关系:确定加拿大儿科慢性疼痛以患者为导向的研究重点的优先事项设定伙伴关系。
Pub Date : 2019-10-01 DOI: 10.9778/cmajo.20190060
K. Birnie, Katherine Dib, Carley Ouellette, Mary Anne Dib, Kimberly Nelson, Dolores Pahtayken, K. Baerg, J. Chorney, P. Forgeron, C. Lamontagne, M. Noel, P. Poulin, J. Stinson
BACKGROUNDChronic pain affects 1-3 million Canadian children and adolescents and their families. The primary objective of the Partnering For Pain project was to collaboratively identify the top 10 research priorities in pediatric chronic pain.METHODSPartnering For Pain took a patient-oriented research approach and followed a modified James Lind Alliance Priority Setting Partnership (PSP) to identify the top research priorities in pediatric chronic pain according to people with lived experience (patients), family members and health care providers (clinicians). The PSP was completed in 4 phases between May and December 2018: 1) national survey of stakeholders, including those with lived experience with pediatric chronic pain, family members and clinicians who treat children with chronic pain, to gather priorities, 2) data processing, 3) interim prioritization by invited patients, family members and clinicians (former research participants or identified through pediatric chronic pain programs, patient partner organizations and steering committee member networks) and 4) in-person priority-setting workshop involving patients, family members and clinicians identified via steering committee networks and partner organizations, with evaluation of patient engagement. The process was led by a national steering committee of patient and parent partners, researchers and clinicians engaged in codesign, analysis and translation of project findings.RESULTSIn phase 1, 215 Canadians (86 patients [40.0%], 56 family members [26.0%] and 73 clinicians [34.0%]) submitted 540 potential priorities that were developed into 112 unique research questions (phase 2). Of the 112 questions, 63 were rated for importance by 57 participants (19 patients [33%], 17 family members [30%] and 21 clinicians [37%]) in phase 3. In phase 4, 20 participants (6 patients [30%], 6 family members [30%] and 8 clinicians [40%]) discussed the 25 most highly rated questions and reached consensus on the final top 10.INTERPRETATIONThe final priorities address pediatric chronic pain prevention, impact and treatment, as well as delivery, access and coordination of care. The priorities reflect a directed and collaborative call to action to improve existing pediatric pain research and care.PLAIN LANGUAGE SUMMARYChronic pain affects 1 in 5 children and teens. This means that 1-3 million Canadian youth deal with pain lasting months to years. This pain gets in the way of being active, sleeping, going to school, and getting along with friends and family. Youth with chronic pain and their families are experts on what it's like to live with pain, but, until now, research has not asked what issues they care about most. The goal of the Partnering For Pain project was to develop a list of the 10 most important things we still need to learn about chronic pain during childhood according to people who live with it, their families and health care providers. We did this in 4 steps: 1) a survey with 215
背景:慢性疼痛影响着加拿大1-3百万儿童和青少年及其家庭。疼痛合作项目的主要目标是共同确定儿科慢性疼痛的十大研究重点。方法采用以患者为导向的研究方法,并遵循改进的James Lind联盟优先设定伙伴关系(PSP),根据有生活经验的人(患者)、家庭成员和医疗保健提供者(临床医生)确定儿科慢性疼痛的优先研究重点。PSP于2018年5月至12月分四期完成:1)在全国范围内对利益相关者进行调查,包括有儿童慢性疼痛生活经验的人、家庭成员和治疗儿童慢性疼痛的临床医生,以收集优先事项;2)数据处理;3)邀请患者、家庭成员和临床医生(前研究参与者或通过儿科慢性疼痛项目确定)临时优先事项;患者伙伴组织和指导委员会成员网络)和4)通过指导委员会网络和伙伴组织确定的患者、家庭成员和临床医生参与的面对面优先事项设置研讨会,并评估患者参与情况。该过程由一个由患者和家长合作伙伴、研究人员和临床医生组成的国家指导委员会领导,共同设计、分析和翻译项目发现。在第1期,215名加拿大人(86名患者[40.0%],56名家庭成员[26.0%]和73名临床医生[34.0%])提交了540个潜在的优先事项,这些优先事项被开发成112个独特的研究问题(第2期)。在第3期,57名参与者(19名患者[33%],17名家庭成员[30%]和21名临床医生[37%])对112个问题的重要性进行了评估。在第4阶段,20名参与者(6名患者[30%],6名家庭成员[30%]和8名临床医生[40%])讨论了评价最高的25个问题,并就最终的前10个问题达成了共识。最后的重点是儿童慢性疼痛的预防、影响和治疗,以及护理的提供、获取和协调。优先事项反映了直接和协作呼吁采取行动,以改善现有的儿科疼痛研究和护理。慢性疼痛影响着五分之一的儿童和青少年。这意味着1-3百万加拿大年轻人要忍受持续数月至数年的疼痛。这种疼痛妨碍了活动、睡眠、上学以及与朋友和家人相处。患有慢性疼痛的年轻人和他们的家人都是专家,知道疼痛是什么感觉,但是,直到现在,研究还没有问他们最关心的问题是什么。“为疼痛而合作”项目的目标是根据患有慢性疼痛的人、他们的家人和医疗保健提供者的意见,列出我们仍然需要了解的关于儿童慢性疼痛的10件最重要的事情。我们分四个步骤进行:1)对215人进行调查,这些人分享了他们对童年慢性疼痛的540个担忧;2)将这些担忧转化为可以通过研究回答的问题;3)对57人进行调查,对每个研究问题的重要性进行排名;4)与20人进行面对面讨论,选择10个最重要的研究重点。每一步都包括童年时期患有慢性疼痛的加拿大人、他们的家人和卫生保健提供者。最后的十大问题是关于如何更好地预防和照顾患有慢性疼痛的儿童和青少年。这些优先事项确保了未来的研究将重点放在那些在日常生活中使用它的人最重要的东西上。项目视频:https://youtu.be/wA-RwrFiSPk。项目网站:www.partneringforpain.com。
{"title":"Partnering For Pain: a Priority Setting Partnership to identify patient-oriented research priorities for pediatric chronic pain in Canada.","authors":"K. Birnie, Katherine Dib, Carley Ouellette, Mary Anne Dib, Kimberly Nelson, Dolores Pahtayken, K. Baerg, J. Chorney, P. Forgeron, C. Lamontagne, M. Noel, P. Poulin, J. Stinson","doi":"10.9778/cmajo.20190060","DOIUrl":"https://doi.org/10.9778/cmajo.20190060","url":null,"abstract":"BACKGROUND\u0000Chronic pain affects 1-3 million Canadian children and adolescents and their families. The primary objective of the Partnering For Pain project was to collaboratively identify the top 10 research priorities in pediatric chronic pain.\u0000\u0000\u0000METHODS\u0000Partnering For Pain took a patient-oriented research approach and followed a modified James Lind Alliance Priority Setting Partnership (PSP) to identify the top research priorities in pediatric chronic pain according to people with lived experience (patients), family members and health care providers (clinicians). The PSP was completed in 4 phases between May and December 2018: 1) national survey of stakeholders, including those with lived experience with pediatric chronic pain, family members and clinicians who treat children with chronic pain, to gather priorities, 2) data processing, 3) interim prioritization by invited patients, family members and clinicians (former research participants or identified through pediatric chronic pain programs, patient partner organizations and steering committee member networks) and 4) in-person priority-setting workshop involving patients, family members and clinicians identified via steering committee networks and partner organizations, with evaluation of patient engagement. The process was led by a national steering committee of patient and parent partners, researchers and clinicians engaged in codesign, analysis and translation of project findings.\u0000\u0000\u0000RESULTS\u0000In phase 1, 215 Canadians (86 patients [40.0%], 56 family members [26.0%] and 73 clinicians [34.0%]) submitted 540 potential priorities that were developed into 112 unique research questions (phase 2). Of the 112 questions, 63 were rated for importance by 57 participants (19 patients [33%], 17 family members [30%] and 21 clinicians [37%]) in phase 3. In phase 4, 20 participants (6 patients [30%], 6 family members [30%] and 8 clinicians [40%]) discussed the 25 most highly rated questions and reached consensus on the final top 10.\u0000\u0000\u0000INTERPRETATION\u0000The final priorities address pediatric chronic pain prevention, impact and treatment, as well as delivery, access and coordination of care. The priorities reflect a directed and collaborative call to action to improve existing pediatric pain research and care.\u0000\u0000\u0000PLAIN LANGUAGE SUMMARY\u0000Chronic pain affects 1 in 5 children and teens. This means that 1-3 million Canadian youth deal with pain lasting months to years. This pain gets in the way of being active, sleeping, going to school, and getting along with friends and family. Youth with chronic pain and their families are experts on what it's like to live with pain, but, until now, research has not asked what issues they care about most. The goal of the Partnering For Pain project was to develop a list of the 10 most important things we still need to learn about chronic pain during childhood according to people who live with it, their families and health care providers. We did this in 4 steps: 1) a survey with 215","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20190060","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45476764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 41
Prescription medication nonadherence associated with food insecurity: a population-based cross-sectional study. 与粮食不安全相关的处方药不依从性:一项基于人群的横断面研究。
Pub Date : 2019-09-23 Print Date: 2019-07-01 DOI: 10.9778/cmajo.20190075
Fei Men, Craig Gundersen, Marcelo L Urquia, Valerie Tarasuk

Background: Food insecurity, defined as inadequate access to food owing to financial constraints, has been associated with poor disease management. Because cost-related nonadherence to prescription drugs is a possible explanation for such association, we examined the link between food insecurity and cost-related medication nonadherence in Canada.

Methods: Drawing on data for adult respondents (age ≥ 18 yr) who participated in the Canadian Community Health Survey 2016 Rapid Response module on prescription medication use, we assessed the association between household food insecurity and cost-related nonadherence to prescription drugs in the previous 12 months. We further examined the self-perceived health consequences of cost-related nonadherence among nonadherents. We applied Poisson models with bootstrap weights adjusting for sociodemographic characteristics.

Results: Of the 11 172 respondents in our sample, 930 (8.3%) reported cost-related nonadherence. Food insecurity affected 10.5% (95% confidence interval [CI] 9.1% to 11.8%) of adherents and 47.9% (95% CI 38.1% to 57.7%) of nonadherents. After adjustment for confounders, moderate and severe food insecurity were associated with 3.83 (95% CI 2.44 to 6.03) and 5.05 (95% CI 3.27 to 7.81) times higher prevalence of cost-related nonadherence, respectively, relative to food security. Despite being associated with lower probability of cost-related nonadherence, having drug insurance did not change the relation between food insecurity and cost-related nonadherence (p > 0.1 for all interactions). Severe food insecurity was correlated with higher prevalence of health deterioration and greater use of health care services as perceived consequences of cost-related nonadherence (p < 0.01 for both).

Interpretation: Food-insecure adults in Canada have a higher likelihood of cost-related nonadherence to prescription medications than their food-secure counterparts, which may constitute a burden on their health and lead to greater use of health care services.

背景:粮食不安全被定义为由于财政限制而无法充分获得粮食,这与疾病管理不善有关。由于与成本相关的不遵守处方药是这种关联的可能解释,我们研究了加拿大粮食不安全与与与成本相关药物不遵守之间的联系。方法:利用参与2016年加拿大社区健康调查处方药使用快速反应模块的成年受访者(年龄≥18岁)的数据,我们评估了家庭粮食不安全与过去12个月内与成本相关的不遵守处方药之间的关系。我们进一步研究了不依从性人群中与成本相关的不依从性的自我感知健康后果。我们应用了具有bootstrap权重的泊松模型,根据社会人口统计特征进行调整。结果:在我们样本中的1172名受访者中,930人(8.3%)报告了与成本相关的不遵守。粮食不安全影响了10.5%(95%置信区间[CI]9.1%至11.8%)的追随者和47.9%(95%可信区间38.1%至57.7%)的非追随者。在对混杂因素进行校正后,相对于粮食安全,中度和重度粮食不安全与成本相关不依从性的发生率分别高3.83倍(95%CI 2.44-6.03)和5.05倍(95%CI3.27-7.81)相关。尽管与较低的成本相关不履约概率有关,但有药物保险并没有改变粮食不安全和成本相关不遵守之间的关系(所有相互作用的p>0.1)。严重的粮食不安全与更高的健康恶化率和更多地使用医疗保健服务相关,这是与成本相关的不依从性的感知后果(两者均p<0.01),这可能对他们的健康构成负担,并导致更多地使用医疗保健服务。
{"title":"Prescription medication nonadherence associated with food insecurity: a population-based cross-sectional study.","authors":"Fei Men,&nbsp;Craig Gundersen,&nbsp;Marcelo L Urquia,&nbsp;Valerie Tarasuk","doi":"10.9778/cmajo.20190075","DOIUrl":"https://doi.org/10.9778/cmajo.20190075","url":null,"abstract":"<p><strong>Background: </strong>Food insecurity, defined as inadequate access to food owing to financial constraints, has been associated with poor disease management. Because cost-related nonadherence to prescription drugs is a possible explanation for such association, we examined the link between food insecurity and cost-related medication nonadherence in Canada.</p><p><strong>Methods: </strong>Drawing on data for adult respondents (age ≥ 18 yr) who participated in the Canadian Community Health Survey 2016 Rapid Response module on prescription medication use, we assessed the association between household food insecurity and cost-related nonadherence to prescription drugs in the previous 12 months. We further examined the self-perceived health consequences of cost-related nonadherence among nonadherents. We applied Poisson models with bootstrap weights adjusting for sociodemographic characteristics.</p><p><strong>Results: </strong>Of the 11 172 respondents in our sample, 930 (8.3%) reported cost-related nonadherence. Food insecurity affected 10.5% (95% confidence interval [CI] 9.1% to 11.8%) of adherents and 47.9% (95% CI 38.1% to 57.7%) of nonadherents. After adjustment for confounders, moderate and severe food insecurity were associated with 3.83 (95% CI 2.44 to 6.03) and 5.05 (95% CI 3.27 to 7.81) times higher prevalence of cost-related nonadherence, respectively, relative to food security. Despite being associated with lower probability of cost-related nonadherence, having drug insurance did not change the relation between food insecurity and cost-related nonadherence (<i>p</i> > 0.1 for all interactions). Severe food insecurity was correlated with higher prevalence of health deterioration and greater use of health care services as perceived consequences of cost-related nonadherence (<i>p</i> < 0.01 for both).</p><p><strong>Interpretation: </strong>Food-insecure adults in Canada have a higher likelihood of cost-related nonadherence to prescription medications than their food-secure counterparts, which may constitute a burden on their health and lead to greater use of health care services.</p>","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20190075","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study. 安大略省西北部原住民社区成年人慢性肾脏疾病和心血管合并症的患病率:一项回顾性观察性研究。
Pub Date : 2019-09-09 Print Date: 2019-07-01 DOI: 10.9778/cmajo.20190040
Len Kelly, Cai-Lei Matsumoto, Yoko Schreiber, Janet Gordon, Hannah Willms, Christopher Olivier, Sharen Madden, Josh Hopko, Sheldon W Tobe

Background: The prevalence of adult chronic kidney disease and cardiovascular comorbidities in Canadian Indigenous communities is largely unknown. We conducted a study to document the prevalence of chronic kidney disease and concurrent diabetes mellitus, hypertension and dyslipidemia in a First Nations population in northwest Ontario.

Methods: In this observational study, we used retrospective data collected from regional electronic medical records of 16 170 adults (age ≥ 18 yr) from 26 First Nations communities in northwest Ontario from May 2014 to May 2017. Demographic and laboratory data included age, gender, prescribed medications, estimated glomerular filtration rate, urine albumin:creatinine ratio, low-density lipoprotein cholesterol (LDL-C) level and glycated hemoglobin (HbA1c) concentration. We identified patients with diabetes by an HbA1c concentration of 6.5% or higher, or the use of a diabetic medication, those with dyslipidemia by an elevated LDL-C level (≥ 2.0 mmol/L) or use of lipid-lowering medication, and those with hypertension by use of antihypertensive medication.

Results: Of the 16 170 adults residing in the communities, 5224 unique patients (32.3%) had renal testing (albumin:creatinine ratio and/or estimated glomerular filtration rate). The age-adjusted prevalence of chronic kidney disease was 14.5%, and the prevalence of stage 3-5 chronic kidney disease (estimated glomerular filtration rate < 60 mL/min) was 7.0%. Most patients with chronic kidney disease (1487 [80.0%]) had at least 1 cardiovascular comorbidity. A total of 1332 patients (71.6%) had diabetes, 1313 (70.6%) had dyslipidemia, and 1098 (59.1%) had hypertension; all 3 comorbidities were present in 716 patients (38.5%).

Interpretation: We document a high prevalence of advanced chronic kidney disease in this First Nations population, 7.0%, double the rate in the general population. High rates of cardiovascular comorbidities were also common in these patients with chronic kidney disease, which places them at increased risk for cardiovascular disease.

背景:加拿大土著社区成人慢性肾脏疾病和心血管合并症的患病率在很大程度上是未知的。我们进行了一项研究,以记录安大略省西北部原住民人群中慢性肾脏疾病和并发糖尿病、高血压和血脂异常的患病率。方法:在这项观察性研究中,我们使用了2014年5月至2017年5月从安大略省西北部26个原住民社区的16170名成年人(年龄≥18岁)的区域电子医疗记录中收集的回顾性数据。人口统计学和实验室数据包括年龄、性别、处方药、估计肾小球滤过率、尿白蛋白与肌酐比率、低密度脂蛋白胆固醇(LDL-C)水平和糖化血红蛋白(HbA1c)浓度。我们通过HbA1c浓度为6.5%或更高或使用糖尿病药物来确定糖尿病患者,通过LDL-C水平升高(≥2.0 mmol/L)或使用降脂药物来确定血脂异常患者,以及通过使用降压药物来确定高血压患者。结果:在居住在社区的16170名成年人中,5224名独特的患者(32.3%)进行了肾脏测试(白蛋白:肌酐比率和/或估计的肾小球滤过率)。经年龄调整的慢性肾脏疾病患病率为14.5%,3-5期慢性肾脏疾病(估计肾小球滤过率<60 mL/min)的患病率为7.0%。大多数慢性肾脏疾病患者(1487[80.0%])至少有1种心血管共病。共有1332名患者(71.6%)患有糖尿病,1313名患者(70.6%)患有血脂异常,1098名患者(59.1%)患有高血压;所有3种合并症均发生在716名患者中(38.5%)。解释:我们记录了该原住民人群中晚期慢性肾脏疾病的高患病率,为7.0%,是普通人群的两倍。心血管合并症的高发病率在这些慢性肾脏疾病患者中也很常见,这使他们患心血管疾病的风险增加。
{"title":"Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study.","authors":"Len Kelly,&nbsp;Cai-Lei Matsumoto,&nbsp;Yoko Schreiber,&nbsp;Janet Gordon,&nbsp;Hannah Willms,&nbsp;Christopher Olivier,&nbsp;Sharen Madden,&nbsp;Josh Hopko,&nbsp;Sheldon W Tobe","doi":"10.9778/cmajo.20190040","DOIUrl":"https://doi.org/10.9778/cmajo.20190040","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of adult chronic kidney disease and cardiovascular comorbidities in Canadian Indigenous communities is largely unknown. We conducted a study to document the prevalence of chronic kidney disease and concurrent diabetes mellitus, hypertension and dyslipidemia in a First Nations population in northwest Ontario.</p><p><strong>Methods: </strong>In this observational study, we used retrospective data collected from regional electronic medical records of 16 170 adults (age ≥ 18 yr) from 26 First Nations communities in northwest Ontario from May 2014 to May 2017. Demographic and laboratory data included age, gender, prescribed medications, estimated glomerular filtration rate, urine albumin:creatinine ratio, low-density lipoprotein cholesterol (LDL-C) level and glycated hemoglobin (HbA<sub>1c</sub>) concentration. We identified patients with diabetes by an HbA<sub>1c</sub> concentration of 6.5% or higher, or the use of a diabetic medication, those with dyslipidemia by an elevated LDL-C level (≥ 2.0 mmol/L) or use of lipid-lowering medication, and those with hypertension by use of antihypertensive medication.</p><p><strong>Results: </strong>Of the 16 170 adults residing in the communities, 5224 unique patients (32.3%) had renal testing (albumin:creatinine ratio and/or estimated glomerular filtration rate). The age-adjusted prevalence of chronic kidney disease was 14.5%, and the prevalence of stage 3-5 chronic kidney disease (estimated glomerular filtration rate < 60 mL/min) was 7.0%. Most patients with chronic kidney disease (1487 [80.0%]) had at least 1 cardiovascular comorbidity. A total of 1332 patients (71.6%) had diabetes, 1313 (70.6%) had dyslipidemia, and 1098 (59.1%) had hypertension; all 3 comorbidities were present in 716 patients (38.5%).</p><p><strong>Interpretation: </strong>We document a high prevalence of advanced chronic kidney disease in this First Nations population, 7.0%, double the rate in the general population. High rates of cardiovascular comorbidities were also common in these patients with chronic kidney disease, which places them at increased risk for cardiovascular disease.</p>","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20190040","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort study. 人口统计学特征和治疗费用的肿瘤患者在一个公共资助的系统,安大略万亿药物计划:一个回顾性队列研究。
Pub Date : 2019-07-01 DOI: 10.9778/cmajo.20190011
Stephanie Y Cheng, F. Saxena, S. Seung, C. Earle, Kelvin K. W. Chan, N. Mittmann
BACKGROUNDThe aim of this study was to characterize the demographic characteristics and investigate the cost of a publicly funded system, the Ontario Trillium Drug Program (TDP), for an oncology patient population.METHODSWe ascertained all TDP claims between April 1997 and December 2016 from the Ontario Drug Benefit database to assess use and cost. Each drug was classified as a cancer treatment drug, cancer supportive therapy drug or noncancer drug. We also identified a cohort of patients with cancer with least 1 TDP claim, for whom we examined demographic and claims-related characteristics.RESULTSOver the study period, 50 975 293 TDP claims totalling $4.8 billion were made. Although the proportion of cancer claims among all TDP claims remained constant between 1997 and 2016, the total annual cost of cancer treatment drugs increased nearly 40-fold. Imatinib and lenalidomide together accounted for nearly half of the cost of all cancer treatment drugs. We identified a cohort of 49 892 patients with cancer, of whom 18 631 (37.3%) were enrolled in the TDP before their cancer diagnosis and 31 261 (62.7%) were enrolled after their diagnosis. The former were more likely than the latter to be in lower income quintiles and to have more chronic conditions. Significant differences were also found in the distribution of cancer diagnoses between the 2 groups.INTERPRETATIONIn the TDP, use increased over time and differed across cancer diagnoses and drugs. These results have public health and policy implications as antineoplastic drug costs continue to rise and place a burden on patients.
背景本研究的目的是描述人口统计学特征,并调查安大略延龄草药物计划(TDP)这一公共资助系统对肿瘤患者群体的成本。方法我们从安大略省药品福利数据库中确定了1997年4月至2016年12月期间的所有TDP索赔,以评估使用和成本。每种药物都被分类为癌症治疗药物、癌症支持治疗药物或非癌症药物。我们还确定了一组至少有1个TDP索赔的癌症患者,我们检查了他们的人口统计学和索赔相关特征。结果在研究期间,共提出了50 975 293 TDP索赔,总额为48亿美元。尽管癌症索赔在所有TDP索赔中的比例在1997年至2016年间保持不变,但癌症治疗药物的年度总成本增长了近40倍。伊马替尼和来那度胺合计占所有癌症治疗药物成本的近一半。我们确定了一个由49892名癌症患者组成的队列,其中18631人(37.3%)在诊断癌症前加入TDP,31261人(62.7%)在诊断后加入TDP。前者比后者更有可能处于低收入的五分之一人群中,并患有更慢性的疾病。两组之间癌症诊断的分布也存在显著差异。解释在TDP中,使用随着时间的推移而增加,并且在癌症诊断和药物中有所不同。这些结果对公共卫生和政策有影响,因为抗肿瘤药物的成本持续上升,给患者带来了负担。
{"title":"Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort study.","authors":"Stephanie Y Cheng, F. Saxena, S. Seung, C. Earle, Kelvin K. W. Chan, N. Mittmann","doi":"10.9778/cmajo.20190011","DOIUrl":"https://doi.org/10.9778/cmajo.20190011","url":null,"abstract":"BACKGROUND\u0000The aim of this study was to characterize the demographic characteristics and investigate the cost of a publicly funded system, the Ontario Trillium Drug Program (TDP), for an oncology patient population.\u0000\u0000\u0000METHODS\u0000We ascertained all TDP claims between April 1997 and December 2016 from the Ontario Drug Benefit database to assess use and cost. Each drug was classified as a cancer treatment drug, cancer supportive therapy drug or noncancer drug. We also identified a cohort of patients with cancer with least 1 TDP claim, for whom we examined demographic and claims-related characteristics.\u0000\u0000\u0000RESULTS\u0000Over the study period, 50 975 293 TDP claims totalling $4.8 billion were made. Although the proportion of cancer claims among all TDP claims remained constant between 1997 and 2016, the total annual cost of cancer treatment drugs increased nearly 40-fold. Imatinib and lenalidomide together accounted for nearly half of the cost of all cancer treatment drugs. We identified a cohort of 49 892 patients with cancer, of whom 18 631 (37.3%) were enrolled in the TDP before their cancer diagnosis and 31 261 (62.7%) were enrolled after their diagnosis. The former were more likely than the latter to be in lower income quintiles and to have more chronic conditions. Significant differences were also found in the distribution of cancer diagnoses between the 2 groups.\u0000\u0000\u0000INTERPRETATION\u0000In the TDP, use increased over time and differed across cancer diagnoses and drugs. These results have public health and policy implications as antineoplastic drug costs continue to rise and place a burden on patients.","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20190011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44955713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study. 合法化后6个月进入加拿大各地的大麻零售店:一项描述性研究。
Pub Date : 2019-07-01 DOI: 10.9778/cmajo.20190012
D. Myran, Catherine R L Brown, P. Tanuseputro
BACKGROUNDOn Oct. 17, 2018, Canada legalized recreational cannabis with the dual goals of reducing youth use and eliminating the illicit cannabis market. We examined factors associated with access to physical cannabis stores across Canada 6 months following legalization.METHODSWe extracted the address and operating hours of all legal cannabis stores in Canada from online government and private listings. We conducted a descriptive study examining the association between private/hybrid (mixture of government and private stores) and government-only retail models with 4 measures of physical access to cannabis: store density, weekly hours of operation, median distance to the nearest school and relative availability of cannabis stores between low- and high-income neighbourhoods.RESULTSSix months after legalization, there were 260 cannabis retail stores across Canada: 181 privately run stores, 55 government-run stores and 24 stores in the hybrid retail system. Compared to jurisdictions with a government-run model, jurisdictions with a private/hybrid retail model had 49% (95% confidence interval 10%-200%) more stores per capita, retailers were open on average 9.2 more hours per week, and stores were located closer to schools (median 166.7 m). In both retail models, there was over twice the concentration of cannabis stores in neighbourhoods in the lowest income quintile compared to the highest income quintile.INTERPRETATIONMarked differences in physical access to cannabis retail are emerging between jurisdictions with private/hybrid retail models and those with government-only retail models. Ongoing surveillance including monitoring differences in cannabis use and harms across jurisdictions is needed.
背景2018年10月17日,加拿大将娱乐性大麻合法化,其双重目标是减少青少年使用和消除非法大麻市场。我们研究了在合法化6个月后,加拿大各地进入实体大麻商店的相关因素。方法我们从政府和私人的在线列表中提取了加拿大所有合法大麻商店的地址和营业时间。我们进行了一项描述性研究,研究了私人/混合型(政府和私人商店的混合物)和仅政府零售模式之间的关系,并对大麻的实际获取情况进行了4项衡量:商店密度、每周营业时间、到最近学校的中位距离以及低收入和高收入社区之间大麻商店的相对可用性。结果合法化六个月后,加拿大共有260家大麻零售店:181家私人经营的商店、55家政府经营的商店和24家混合零售系统商店。与采用政府经营模式的司法管辖区相比,采用私人/混合零售模式的司法辖区的人均门店数增加了49%(95%置信区间10%-200%),零售商平均每周营业9.2小时,门店距离学校更近(中位数1.667亿)。在这两种零售模式中,收入最低的五分之一人群的大麻商店集中度是收入最高的五分之二人群的两倍多。解释采用私人/混合零售模式的司法管辖区与仅采用政府零售模式的管辖区在大麻零售的实际获取方面出现了显著差异。需要持续监测,包括监测不同司法管辖区大麻使用和危害的差异。
{"title":"Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study.","authors":"D. Myran, Catherine R L Brown, P. Tanuseputro","doi":"10.9778/cmajo.20190012","DOIUrl":"https://doi.org/10.9778/cmajo.20190012","url":null,"abstract":"BACKGROUND\u0000On Oct. 17, 2018, Canada legalized recreational cannabis with the dual goals of reducing youth use and eliminating the illicit cannabis market. We examined factors associated with access to physical cannabis stores across Canada 6 months following legalization.\u0000\u0000\u0000METHODS\u0000We extracted the address and operating hours of all legal cannabis stores in Canada from online government and private listings. We conducted a descriptive study examining the association between private/hybrid (mixture of government and private stores) and government-only retail models with 4 measures of physical access to cannabis: store density, weekly hours of operation, median distance to the nearest school and relative availability of cannabis stores between low- and high-income neighbourhoods.\u0000\u0000\u0000RESULTS\u0000Six months after legalization, there were 260 cannabis retail stores across Canada: 181 privately run stores, 55 government-run stores and 24 stores in the hybrid retail system. Compared to jurisdictions with a government-run model, jurisdictions with a private/hybrid retail model had 49% (95% confidence interval 10%-200%) more stores per capita, retailers were open on average 9.2 more hours per week, and stores were located closer to schools (median 166.7 m). In both retail models, there was over twice the concentration of cannabis stores in neighbourhoods in the lowest income quintile compared to the highest income quintile.\u0000\u0000\u0000INTERPRETATION\u0000Marked differences in physical access to cannabis retail are emerging between jurisdictions with private/hybrid retail models and those with government-only retail models. Ongoing surveillance including monitoring differences in cannabis use and harms across jurisdictions is needed.","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20190012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44963896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Exploring the approaches of non-Indigenous researchers to Indigenous research: a qualitative study. 探索非土著研究人员对土著研究的方法:一项定性研究。
Pub Date : 2019-07-01 DOI: 10.9778/cmajo.20180204
Alexandra Kilian, T. K. Fellows, Ryan Giroux, Jason Pennington, A. Kuper, C. Whitehead, Lisa Richardson
BACKGROUNDGiven the history of unethical research in Indigenous communities, there is often apprehension among Indigenous communities toward research carried out by non-Indigenous researchers. We examined the approaches, experiences and motivations among non-Indigenous researchers at a research-intensive Canadian university conducting research with Indigenous communities to understand approaches to ethical research with Indigenous peoples.METHODSWe performed a critical constructivist qualitative study incorporating decolonizing methodologies. We conducted semistructured interviews with 8 non-Indigenous University of Toronto researchers with a research focus/interest related to Indigenous health between August and October 2017. The interviews were transcribed and thematically analyzed through an iterative process. Shared experiences among the researchers were arranged into primary themes.RESULTSWe identified 4 primary themes related to the conduct of Indigenous research by non-Indigenous researchers: 1) relationships with communities are foundational to the research process, 2) non-Indigenous researchers experience a personal self-reflective journey grounded in reconciliation, allyship and privilege, 3) accepted knowledge frameworks in Indigenous research are familiar to most but are inconsistently applied and 4) institutions act as barriers to and facilitators of ethical conduct of Indigenous research. Four core principles - relationships, trust, humility and accountability - unified the primary themes.INTERPRETATIONWe identified strengths and areas for improvement of current policies and practices in Indigenous research by non-Indigenous researchers. Although non-Indigenous researchers value relationships, and their research is informed by Indigenous knowledge, institutional barriers to implementing recommended elements exist, and certain policy statements such as the Tri-Council Policy Statement 2 lack applicability to secondary data analysis for some non-Indigenous researchers.
背景考虑到土著社区不道德研究的历史,土著社区经常对非土著研究人员进行的研究感到担忧。我们研究了加拿大一所研究密集型大学的非土著研究人员的方法、经验和动机,该大学与土著社区进行研究,以了解与土著人民进行伦理研究的方法。方法我们进行了一项批判性的建构主义定性研究,结合了非殖民化方法。2017年8月至10月,我们对多伦多大学的8名非土著研究人员进行了半结构化访谈,他们的研究重点/兴趣与土著健康有关。访谈被转录下来,并通过迭代过程进行主题分析。研究人员之间的共同经历被安排为主要主题。结果我们确定了与非土著研究人员进行土著研究有关的4个主要主题:1)与社区的关系是研究过程的基础,3)大多数人都熟悉土著研究中公认的知识框架,但应用不一致;4)机构是土著研究伦理行为的障碍和推动者。四项核心原则——关系、信任、谦逊和问责——统一了主要主题。解释我们确定了非土著研究人员在土著研究方面当前政策和做法的优势和改进领域。尽管非土著研究人员重视关系,他们的研究是根据土著知识进行的,但在实施建议要素方面存在体制障碍,某些政策声明,如三委员会政策声明2,不适用于一些非土著研究者的二次数据分析。
{"title":"Exploring the approaches of non-Indigenous researchers to Indigenous research: a qualitative study.","authors":"Alexandra Kilian, T. K. Fellows, Ryan Giroux, Jason Pennington, A. Kuper, C. Whitehead, Lisa Richardson","doi":"10.9778/cmajo.20180204","DOIUrl":"https://doi.org/10.9778/cmajo.20180204","url":null,"abstract":"BACKGROUND\u0000Given the history of unethical research in Indigenous communities, there is often apprehension among Indigenous communities toward research carried out by non-Indigenous researchers. We examined the approaches, experiences and motivations among non-Indigenous researchers at a research-intensive Canadian university conducting research with Indigenous communities to understand approaches to ethical research with Indigenous peoples.\u0000\u0000\u0000METHODS\u0000We performed a critical constructivist qualitative study incorporating decolonizing methodologies. We conducted semistructured interviews with 8 non-Indigenous University of Toronto researchers with a research focus/interest related to Indigenous health between August and October 2017. The interviews were transcribed and thematically analyzed through an iterative process. Shared experiences among the researchers were arranged into primary themes.\u0000\u0000\u0000RESULTS\u0000We identified 4 primary themes related to the conduct of Indigenous research by non-Indigenous researchers: 1) relationships with communities are foundational to the research process, 2) non-Indigenous researchers experience a personal self-reflective journey grounded in reconciliation, allyship and privilege, 3) accepted knowledge frameworks in Indigenous research are familiar to most but are inconsistently applied and 4) institutions act as barriers to and facilitators of ethical conduct of Indigenous research. Four core principles - relationships, trust, humility and accountability - unified the primary themes.\u0000\u0000\u0000INTERPRETATION\u0000We identified strengths and areas for improvement of current policies and practices in Indigenous research by non-Indigenous researchers. Although non-Indigenous researchers value relationships, and their research is informed by Indigenous knowledge, institutional barriers to implementing recommended elements exist, and certain policy statements such as the Tri-Council Policy Statement 2 lack applicability to secondary data analysis for some non-Indigenous researchers.","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20180204","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44406371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviews. 跨性别者的乳腺癌症风险和乳腺筛查:3项系统综述的整合。
Pub Date : 2019-07-01 DOI: 10.9778/cmajo.20180028
Olivia Meggetto, L. Peirson, M. Yakubu, Mufiza Farid-Kapadia, Michelle Costa-Fagbemi, S. Baidoobonso, J. Moffatt, Lauren Chun, A. Chiarelli, D. Muradali
BACKGROUNDTrans people face uncertain risk for breast cancer and barriers to accessing breast screening. Our objectives were to identify and synthesize primary research evidence on the effect of cross-sex hormones (CSHs) on breast cancer risk, prognosis and mortality among trans people, the benefits and harms of breast screening in this population, and existing clinical practice recommendations on breast screening for trans people.METHODSWe conducted 2 systematic reviews of primary research, 1 on the effect of CSHs on breast cancer risk, prognosis and mortality, and the other on the benefits and harms of breast screening, and a third systematic review of guidelines on existing screening recommendations for trans people. We searched PubMed, MEDLINE, Embase, CINAHL, the Cochrane Database of Systematic Reviews and grey literature sources for primary research, guidelines and position statements published in English between 1997 and 2017. Citations were screened by 2 independent reviewers. One reviewer extracted data and assessed methodological quality of included articles; a second reviewer verified these in full. The results were synthesized narratively.RESULTSFour observational studies, 6 guidelines and 5 position statements were included. Observational evidence of very low certainty did not show an effect of CSHs on breast cancer risk in trans men or trans women. Among trans women, painfulness of mammography and ultrasonography was low. There was no evidence on the effect of CSHs on breast cancer prognosis and mortality, or on benefits and other harms of screening. Existing clinical practice documents recommended screening for distinct trans subpopulations; however, recommendations varied.INTERPRETATIONThe limited evidence does not show an effect of CSHs on breast cancer risk. Although there is insufficient evidence to determine the potential benefits and harms of breast screening, existing clinical practice documents generally recommend screening for trans people; further large-scale prospective comparative research is needed.
背景跨性别者面临患癌症的不确定风险和获得乳腺筛查的障碍。我们的目的是确定和综合跨性别激素(CSHs)对跨性别者乳腺癌症风险、预后和死亡率的影响、该人群乳腺筛查的益处和危害以及跨性别者现有乳腺筛查临床实践建议的初步研究证据。方法我们对主要研究进行了2次系统回顾,1次是关于CSH对乳腺癌症风险、预后和死亡率的影响,另一次是关于乳腺筛查的益处和危害,第三次是对跨性别者现有筛查建议指南的系统回顾。我们搜索了PubMed、MEDLINE、Embase、CINAHL、Cochrane系统评价数据库和灰色文献来源,以了解1997年至2017年间以英语发表的主要研究、指南和立场声明。引文由2名独立评审员进行筛选。一名评审员提取了数据并评估了收录文章的方法学质量;第二位评审员对这些内容进行了全面验证。结果是叙述性综合的。结果纳入了我们的观察性研究、6项指南和5项立场声明。非常低的确定性的观察证据没有显示CSH对跨性别男性或跨性别女性乳腺癌症风险的影响。在跨性别女性中,乳房X光检查和超声检查的痛苦程度较低。没有证据表明CSHs对癌症预后和死亡率的影响,或对筛查的益处和其他危害的影响。现有的临床实践文件建议对不同的跨性别亚群进行筛查;然而,建议各不相同。解释有限的证据并没有显示CSH对乳腺癌症风险的影响。尽管没有足够的证据来确定乳腺筛查的潜在益处和危害,但现有的临床实践文件通常建议对跨性别者进行筛查;需要进一步进行大规模的前瞻性比较研究。
{"title":"Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviews.","authors":"Olivia Meggetto, L. Peirson, M. Yakubu, Mufiza Farid-Kapadia, Michelle Costa-Fagbemi, S. Baidoobonso, J. Moffatt, Lauren Chun, A. Chiarelli, D. Muradali","doi":"10.9778/cmajo.20180028","DOIUrl":"https://doi.org/10.9778/cmajo.20180028","url":null,"abstract":"BACKGROUND\u0000Trans people face uncertain risk for breast cancer and barriers to accessing breast screening. Our objectives were to identify and synthesize primary research evidence on the effect of cross-sex hormones (CSHs) on breast cancer risk, prognosis and mortality among trans people, the benefits and harms of breast screening in this population, and existing clinical practice recommendations on breast screening for trans people.\u0000\u0000\u0000METHODS\u0000We conducted 2 systematic reviews of primary research, 1 on the effect of CSHs on breast cancer risk, prognosis and mortality, and the other on the benefits and harms of breast screening, and a third systematic review of guidelines on existing screening recommendations for trans people. We searched PubMed, MEDLINE, Embase, CINAHL, the Cochrane Database of Systematic Reviews and grey literature sources for primary research, guidelines and position statements published in English between 1997 and 2017. Citations were screened by 2 independent reviewers. One reviewer extracted data and assessed methodological quality of included articles; a second reviewer verified these in full. The results were synthesized narratively.\u0000\u0000\u0000RESULTS\u0000Four observational studies, 6 guidelines and 5 position statements were included. Observational evidence of very low certainty did not show an effect of CSHs on breast cancer risk in trans men or trans women. Among trans women, painfulness of mammography and ultrasonography was low. There was no evidence on the effect of CSHs on breast cancer prognosis and mortality, or on benefits and other harms of screening. Existing clinical practice documents recommended screening for distinct trans subpopulations; however, recommendations varied.\u0000\u0000\u0000INTERPRETATION\u0000The limited evidence does not show an effect of CSHs on breast cancer risk. Although there is insufficient evidence to determine the potential benefits and harms of breast screening, existing clinical practice documents generally recommend screening for trans people; further large-scale prospective comparative research is needed.","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20180028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42902104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study. 安大略省新老年高成本医疗保健使用者的意外住院指数:一项基于人群的匹配队列研究
Pub Date : 2019-07-01 DOI: 10.9778/cmajo.20180185
S. Muratov, Justin Lee, A. Holbrook, J. Michael Paterson, J. R. Guertin, L. Mbuagbaw, T. Gomes, W. Khuu, P. Pequeno, J. Tarride
BACKGROUNDMost health care spending is concentrated within a small group of high-cost health care users. To inform health policies, we examined the characteristics of index hospital admissions and their predictors among incident older high-cost users compared to older non-high-cost users in Ontario.METHODSUsing Ontario administrative data, we identified incident high-cost users aged 66 years or more and matched them 1:3 on age, gender and Local Health Integration Network with non-high-cost users aged 66 years or more. We defined high-cost users as patients within the top 5% most costly high-cost users during fiscal year 2013/14 but not during 2012/13. An index hospital admission, the main outcome, was defined as the first unplanned hospital admission during 2013/14, with no hospital admissions in the preceding 12 months. Descriptively, we analyzed the attributes of index hospital admissions, including costs. We identified predictors of index hospital admissions using stratified logistic regression.RESULTSOver half (95 375/175 847 [54.2%]) of all high-cost users had an unplanned index hospital admission, compared to 8838/527 541 (1.7%) of non-high-cost users. High-cost users had a poorer health status, longer acute length of stay (mean 7.5 d v. 2.9 d) and more frequent designation as alternate level of care before discharge (20.8% v. 1.7%) than did non-high-cost users. Ten diagnosis codes accounted for roughly one-third of the index hospital admission costs in both cohorts. Although many predictors were similar between the cohorts, a lower risk of an index hospital admission was associated with residence in long-term care, attachment to a primary care provider and recent consultation by a geriatrician among high-cost users.INTERPRETATIONThe high prevalence of index hospital admissions and the corresponding costs are a distinctive feature of incident older high-cost users. Improved access to specialist outpatient care, home-based social care and long-term care when required are worth further investigation.
大多数医疗保健支出集中在一小部分高成本医疗保健使用者中。为了为卫生政策提供信息,我们研究了安大略省老年高费用使用者与老年非高费用使用者的住院指数特征及其预测因子。方法使用安大略省的管理数据,我们确定了66岁及以上的事件高成本用户,并将其与66岁及以上的非高成本用户在年龄、性别和当地健康整合网络上进行1:3匹配。我们将高成本用户定义为2013/14财年最高成本高成本用户前5%的患者,而不是2012/13财年。指数住院是主要结果,被定义为2013/14年度首次计划外住院,在过去12个月内没有住院。描述性地,我们分析了指数住院的属性,包括成本。我们使用分层逻辑回归确定指数住院的预测因子。结果超过一半(95 375/175 847[54.2%])的高费用用户有计划外指标住院,而非高费用用户的这一比例为8838/527 541(1.7%)。与非高费用用户相比,高费用用户的健康状况较差,急性住院时间较长(平均7.5 d对2.9 d),并且在出院前更频繁地指定为替代护理级别(20.8%对1.7%)。在两个队列中,十个诊断代码约占住院费用指数的三分之一。虽然许多预测因素在队列之间相似,但在高成本使用者中,住院指数风险较低与长期护理的居住、与初级保健提供者的联系以及最近与老年医学专家的咨询有关。结论:指数住院率和相应费用的高流行率是事件老年高费用使用者的显著特征。改善专科门诊护理、以家庭为基础的社会护理和必要时的长期护理的机会值得进一步调查。
{"title":"Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study.","authors":"S. Muratov, Justin Lee, A. Holbrook, J. Michael Paterson, J. R. Guertin, L. Mbuagbaw, T. Gomes, W. Khuu, P. Pequeno, J. Tarride","doi":"10.9778/cmajo.20180185","DOIUrl":"https://doi.org/10.9778/cmajo.20180185","url":null,"abstract":"BACKGROUND\u0000Most health care spending is concentrated within a small group of high-cost health care users. To inform health policies, we examined the characteristics of index hospital admissions and their predictors among incident older high-cost users compared to older non-high-cost users in Ontario.\u0000\u0000\u0000METHODS\u0000Using Ontario administrative data, we identified incident high-cost users aged 66 years or more and matched them 1:3 on age, gender and Local Health Integration Network with non-high-cost users aged 66 years or more. We defined high-cost users as patients within the top 5% most costly high-cost users during fiscal year 2013/14 but not during 2012/13. An index hospital admission, the main outcome, was defined as the first unplanned hospital admission during 2013/14, with no hospital admissions in the preceding 12 months. Descriptively, we analyzed the attributes of index hospital admissions, including costs. We identified predictors of index hospital admissions using stratified logistic regression.\u0000\u0000\u0000RESULTS\u0000Over half (95 375/175 847 [54.2%]) of all high-cost users had an unplanned index hospital admission, compared to 8838/527 541 (1.7%) of non-high-cost users. High-cost users had a poorer health status, longer acute length of stay (mean 7.5 d v. 2.9 d) and more frequent designation as alternate level of care before discharge (20.8% v. 1.7%) than did non-high-cost users. Ten diagnosis codes accounted for roughly one-third of the index hospital admission costs in both cohorts. Although many predictors were similar between the cohorts, a lower risk of an index hospital admission was associated with residence in long-term care, attachment to a primary care provider and recent consultation by a geriatrician among high-cost users.\u0000\u0000\u0000INTERPRETATION\u0000The high prevalence of index hospital admissions and the corresponding costs are a distinctive feature of incident older high-cost users. Improved access to specialist outpatient care, home-based social care and long-term care when required are worth further investigation.","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20180185","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41991393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Patterns of opioid prescribing by dentists in a pediatric population: a retrospective observational study. 牙医在儿科人群中开具阿片类药物处方的模式:一项回顾性观察性研究。
Pub Date : 2019-07-01 DOI: 10.9778/cmajo.20190021
D. Matthews, M. Brillant, K. Jimoh, W. Singleton, Pam R McLean-Veysey, I. Sketris
BACKGROUNDDentists are regular prescribers of opioid analgesic medications; however, there are few published data on their prescribing practices for children. The aim of this study was to assess opioid prescribing practices of dentists for pediatric patients.METHODSWe conducted a retrospective study (2011/12 to 2017/18) using administrative health data of opioid prescribing practices of dentists in Nova Scotia for children and adolescents (age < 18 yr). The main variables of interest were opioid "type" and "load" dentists prescribed (number of dispensed prescriptions/yr, days supplied/prescription and dosage/d per prescription in milligrams of morphine equivalents [MME]).RESULTSDentists accounted for a mean of 18.3% (standard deviation 1.5%) of all opioid prescribers for the pediatric population annually but were responsible for 59.9% of all opioid prescriptions and 48.6% of total MME dispensed during the 7-year study period. Oral and maxillofacial surgeons were responsible for 80.7% of all dental-related opioids dispensed. Codeine was most frequently prescribed (78.6% of total MME), followed by oxycodone (11.1%). There were significant downward trends over the study period in the total amount of opioid analgesics dispensed (r = -0.903, p < 0.01), primarily due to a reduction in the total amount of codeine dispensed and number of days supplied per prescription (r = -0.837, p < 0.05). Few opioids were dispensed to children less than 12 years.INTERPRETATIONDentists in Nova Scotia reduced prescriptions of opioids in the pediatric population between 2011/12 and 2017/18, which may indicate that current opioid prescribing principles are influencing dentists' prescribing habits. Nonetheless, patients and parents should receive appropriate counselling as to the proper use, risks, storage and potential for misuse of opioids when prescribed.
背景牙医是阿片类镇痛药物的常规处方医生;然而,很少有关于他们为儿童开处方的公开数据。本研究的目的是评估牙医为儿科患者开具阿片类药物处方的做法。方法我们使用新斯科舍省牙医为儿童和青少年(年龄<18岁)开具阿片类药物处方的行政健康数据进行了一项回顾性研究(2011/12至2017/18)。感兴趣的主要变量是牙医开出的阿片类药物“类型”和“负荷”(每年开出的处方数、提供的天数/处方和每次处方的剂量/d,单位为吗啡当量毫克[MME])阿片类药物处方,占7年研究期间MME总量的48.6%。口腔颌面外科医生负责80.7%的牙科相关阿片类药物的分配。处方最频繁的是可待因(占MME总量的78.6%),其次是羟考酮(11.1%)。在研究期间,阿片类止痛药的总量呈显著下降趋势(r=-0.903,p<0.01),主要是由于处方中可待因的总量和供应天数减少(r=-0.837,p<0.05)。很少有阿片类药物被分配给12岁以下的儿童。解释新斯科舍省的牙医在2011/12年至2017/18年期间减少了儿科人群中的阿片类药物处方,这可能表明当前的阿片处方原则正在影响牙医的处方习惯。尽管如此,患者和家长应接受适当的咨询,了解处方中阿片类药物的正确使用、风险、储存和滥用的可能性。
{"title":"Patterns of opioid prescribing by dentists in a pediatric population: a retrospective observational study.","authors":"D. Matthews, M. Brillant, K. Jimoh, W. Singleton, Pam R McLean-Veysey, I. Sketris","doi":"10.9778/cmajo.20190021","DOIUrl":"https://doi.org/10.9778/cmajo.20190021","url":null,"abstract":"BACKGROUND\u0000Dentists are regular prescribers of opioid analgesic medications; however, there are few published data on their prescribing practices for children. The aim of this study was to assess opioid prescribing practices of dentists for pediatric patients.\u0000\u0000\u0000METHODS\u0000We conducted a retrospective study (2011/12 to 2017/18) using administrative health data of opioid prescribing practices of dentists in Nova Scotia for children and adolescents (age < 18 yr). The main variables of interest were opioid \"type\" and \"load\" dentists prescribed (number of dispensed prescriptions/yr, days supplied/prescription and dosage/d per prescription in milligrams of morphine equivalents [MME]).\u0000\u0000\u0000RESULTS\u0000Dentists accounted for a mean of 18.3% (standard deviation 1.5%) of all opioid prescribers for the pediatric population annually but were responsible for 59.9% of all opioid prescriptions and 48.6% of total MME dispensed during the 7-year study period. Oral and maxillofacial surgeons were responsible for 80.7% of all dental-related opioids dispensed. Codeine was most frequently prescribed (78.6% of total MME), followed by oxycodone (11.1%). There were significant downward trends over the study period in the total amount of opioid analgesics dispensed (r = -0.903, p < 0.01), primarily due to a reduction in the total amount of codeine dispensed and number of days supplied per prescription (r = -0.837, p < 0.05). Few opioids were dispensed to children less than 12 years.\u0000\u0000\u0000INTERPRETATION\u0000Dentists in Nova Scotia reduced prescriptions of opioids in the pediatric population between 2011/12 and 2017/18, which may indicate that current opioid prescribing principles are influencing dentists' prescribing habits. Nonetheless, patients and parents should receive appropriate counselling as to the proper use, risks, storage and potential for misuse of opioids when prescribed.","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20190021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41570441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Patients' and caregivers' perspectives on factors that influence understanding of and adherence to hospital discharge instructions: a qualitative study. 患者和护理人员对影响出院指示理解和遵守的因素的看法:一项定性研究。
Pub Date : 2019-07-01 DOI: 10.9778/cmajo.20180208
Karen Okrainec, Shoshana Hahn-Goldberg, H. Abrams, C. Bell, C. Soong, M. Hart, B. Shea, S. Schmidt, Amy Troup, L. Jeffs
BACKGROUNDMany patients have difficulty understanding and adhering to discharge instructions once home from hospital. We assessed patient and family caregiver perspectives on factors that influence understanding of and adherence to discharge instructions.METHODSWe conducted a qualitative study using semistructured interviews of participants aged 18 years or more enrolled in a multicentre mixed-methods study who were discharged from 3 acute care hospitals across Ontario with a diagnosis of congestive heart failure, chronic obstructive pulmonary disease or pneumonia. Patients were recruited between March and November 2016. We used directed content analysis to derive themes and subthemes.RESULTSTwenty-seven participants (16 patients and 11 family members) described 5 themes that affected their understanding of and adherence to discharge instructions: 1) the role of caregivers, 2) relationships with inpatient and outpatient health care providers, 3) previous hospital stay, 4) barriers to accessing postdischarge care and 5) system-level processes. Subthemes highlighted the importance participants attributed to who provides the instructions, the development of resilience and advocacy through previous admissions, the benefits of addressing language and physical disability barriers, reviewing instructions in a unhurried manner, and ensuring that written instructions are meaningful and actionable.INTERPRETATIONCare transition interventions targeting improved communication are unlikely to improve understanding of and adherence to discharge instructions on their own. A patient-centred framework that promotes positive relationships with a patient's circle of care, reflects previous experiences with discharge, addresses equity barriers, and enhances strategies for patient and caregiver engagement at the time of discharge may optimize understanding and adherence once the patient is home.
背景许多患者出院回家后很难理解和遵守出院指示。我们评估了患者和家庭护理人员对影响理解和遵守出院指示的因素的看法。方法我们对来自安大略省3家急性护理医院的诊断为充血性心力衰竭、慢性阻塞性肺病或肺炎的18岁或以上的参与者进行了一项定性研究,这些参与者参加了一项多中心混合方法研究。患者招募时间为2016年3月至11月。我们使用定向内容分析来推导主题和子主题。结果7名参与者(16名患者和11名家庭成员)描述了影响他们理解和遵守出院指示的5个主题:1)护理人员的角色,2)与住院和门诊医疗服务提供者的关系,3)以前住院过,4)获得出院后护理的障碍,5)系统级流程。子主题强调了参与者对谁提供指导的重要性,通过以前的录取培养了韧性和宣传,解决语言和身体残疾障碍的好处,以从容的方式审查指导,并确保书面指导是有意义和可操作的。解释:旨在改善沟通的护理过渡干预措施本身不太可能提高对出院指示的理解和遵守程度。一个以患者为中心的框架,促进与患者护理圈的积极关系,反映以前出院的经历,解决公平障碍,并增强出院时患者和护理人员参与的策略,可以在患者回家后优化理解和坚持。
{"title":"Patients' and caregivers' perspectives on factors that influence understanding of and adherence to hospital discharge instructions: a qualitative study.","authors":"Karen Okrainec, Shoshana Hahn-Goldberg, H. Abrams, C. Bell, C. Soong, M. Hart, B. Shea, S. Schmidt, Amy Troup, L. Jeffs","doi":"10.9778/cmajo.20180208","DOIUrl":"https://doi.org/10.9778/cmajo.20180208","url":null,"abstract":"BACKGROUND\u0000Many patients have difficulty understanding and adhering to discharge instructions once home from hospital. We assessed patient and family caregiver perspectives on factors that influence understanding of and adherence to discharge instructions.\u0000\u0000\u0000METHODS\u0000We conducted a qualitative study using semistructured interviews of participants aged 18 years or more enrolled in a multicentre mixed-methods study who were discharged from 3 acute care hospitals across Ontario with a diagnosis of congestive heart failure, chronic obstructive pulmonary disease or pneumonia. Patients were recruited between March and November 2016. We used directed content analysis to derive themes and subthemes.\u0000\u0000\u0000RESULTS\u0000Twenty-seven participants (16 patients and 11 family members) described 5 themes that affected their understanding of and adherence to discharge instructions: 1) the role of caregivers, 2) relationships with inpatient and outpatient health care providers, 3) previous hospital stay, 4) barriers to accessing postdischarge care and 5) system-level processes. Subthemes highlighted the importance participants attributed to who provides the instructions, the development of resilience and advocacy through previous admissions, the benefits of addressing language and physical disability barriers, reviewing instructions in a unhurried manner, and ensuring that written instructions are meaningful and actionable.\u0000\u0000\u0000INTERPRETATION\u0000Care transition interventions targeting improved communication are unlikely to improve understanding of and adherence to discharge instructions on their own. A patient-centred framework that promotes positive relationships with a patient's circle of care, reflects previous experiences with discharge, addresses equity barriers, and enhances strategies for patient and caregiver engagement at the time of discharge may optimize understanding and adherence once the patient is home.","PeriodicalId":93946,"journal":{"name":"CMAJ open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.9778/cmajo.20180208","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46793615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
CMAJ open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1